Divis Laboratories and Piramal Pharma Stocks Decline for Fifth Consecutive Session
Divis Laboratories Ltd's stock declined for a fifth consecutive session, trading at around Rs 9,108.5 with a slight daily drop, despite a 50.52% gain over the past year. The Nifty Pharma index, which includes Divis, eased 0.81% in the last month. Similarly, Piramal Pharma Ltd also fell for the fifth straight session, trading near Rs 202.53, with a 1.07% decline over the past month. Both stocks showed lower volumes compared to their monthly averages amid a generally rising Nifty and Sensex.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (47/100). Lens Score 30/100.
Outlets measured: businessstandard, businessstandard, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (42–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 16 Sept, 05:21 am. Other outlets followed.